1-4 of 4
Sheng Cai, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Predictors and Current Management of Minimal Residual Disease (MRD) Following Induction Chemotherapy for Acute Myeloid Leukemia (AML)

Aaron D Goldberg, MDPhD, Christopher Famulare, MS, Sean M Devlin, PhD, Noushin Farnoud, PhD, Kamal Menghrajani, MD, Minal Patel, BA, Sheng Cai, MD PhD, Andrew Dunbar, MD, Zachary D. Epstein-Peterson, MD, Erin McGovern, BA, Jessica Schulman, Jacob L Glass, MDPhD, Justin Taylor, MD, Aaron D Viny, MDMS, Bartlomiej Getta, FRCPA, FRACP, MBBS, Maria E Arcila, MD, Ross L. Levine, MD, Brian C. Shaffer, MD, Boglarka Gyurkocza, MD, Esperanza B. Papadopoulos, MD, Miguel-Angel Perales, MD, Elli Papaemmanuil, PhD, Sergio Giralt, MD, Yanming Zhang, MD, Mikhail Roshal, MD PhD, Martin S. Tallman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 292.
https://doi.org/10.1182/blood-2018-99-112938
Published: 2018
Journal Articles

Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia

Wenbin Xiao, MD, Aaron D Goldberg, MD PhD, Christopher Famulare, MS, Sean Delvin, Minal Patel, BA, Erin McGovern, BA, Akshar Patel, BA, Jessica Schulman, Andrew Dunbar, MD, Zachary D. Epstein-Peterson, MD, Kamal Menghrajani, MD, Bartlomiej Getta, Sheng Cai, MD PhD, Mark Blaine Geyer, MD, Jacob L Glass, MD PhD, Justin Taylor, MD, Aaron D Viny, MD MS, Ross L. Levine, MD, Yanming Zhang, MD, Martin S. Tallman, MD, Mikhail Roshal, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1523.
https://doi.org/10.1182/blood-2018-99-112591
Published: 2018
Journal Articles

LSD1 Inhibition Exerts Its Anti-Leukemic Effect By Recommissioning PU.1- and C/Ebpα-Dependent Enhancers in AML

Monica Cusan, MD, Sheng Cai, MD PhD, Helai P Mohammad, PhD, Andrei V. Krivtsov, PhD, Alan Chramiec, Evangelia Loizou, Daniel G. Tenen, MD, Min Ye, PhD, Britta Will, PhD, Ulrich G. Steidl, MDPhD, Ryan G. Kruger, PhD, Richard Koche, PhD, Scott Armstrong, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 242.
https://doi.org/10.1182/blood.V130.Suppl_1.242.242
Published: 2017
Journal Articles

An Epigenetic Regulator Screen Identifies Novel Targets That Sensitize MLL -Rearranged Leukemia to DOT1L Inhibition

Chun-Wei David Chen, PhD, Christopher Delaney, BS, Haiming Xu, PhD, Richard Koche, PhD, Amaya Lujambio Goizueta, PhD, Takayuki Hoshii, PhD, Monica Cusan, MD PhD, Jonathan Chabon, BS, Daria Gianina Valerio, MD, Michael Kuehn, MD, Xi Wang, BS, Sheng Cai, MD PhD, S. Haihua Chu, PhD, Yining Kevin Chen, Justin He, Chun-Hao Huang, PhD, Zhaohui Feng, BM, BS, Andrei Krivtsov, PhD, Jun Qi, PhD, James E. Bradner, MD, Scott W. Lowe, PhD, Scott A. Armstrong, MD PhD
Journal: Blood
Blood (2016) 128 (22): 571.
https://doi.org/10.1182/blood.V128.22.571.571
Published: 2016